Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial specifically studied a minimally invasive technique for pancreatic enucleation that involves exposing and sometimes repairing the main pancreatic duct — how does that surgical approach compare to what you would recommend for my type of tumor, whether it's a neuroendocrine tumor, solid pseudopapillary tumor, or another benign growth?
2. 2The trial's main outcome was measuring the rate of clinically relevant postoperative pancreatic fistula, which is a known complication after pancreatic surgery — based on the completed results, does this technique appear to lower that risk compared to standard enucleation or a more extensive resection like a pancreatectomy?
3. 3Since this trial is now completed, have you seen or reviewed any findings from it, and do those results influence how you'd approach my case or the surgical technique you'd use?
4. 4Enucleation is generally considered a more organ-sparing approach than a full pancreatic resection — given my specific tumor's size, location, and proximity to the main pancreatic duct, is enucleation even technically feasible for me, or would a different operation be safer?
5. 5The trial involved minimally invasive surgery, such as laparoscopic or robotic techniques — is that kind of approach available at our center for my situation, and what are the tradeoffs in terms of recovery time and complication risk compared to open surgery?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.